Regubeat 100mg Tablet
Prescription Required
Product introduction
Regubeat 100mg Tablet is a medicine used to treat arrhythmia (abnormal heart rhythm). It restores normal heart rhythm by blocking abnormal electrical signals in the heart. This helps to maintain a regular and steady heartbeat.
Regubeat 100mg Tablet controls the uneven beating of the heart and helps it to return to normal
Regubeat 100mg Tablet controls the uneven beating of the heart and helps it to return to normal
Uses of Regubeat Tablet
Benefits of Regubeat Tablet
In Arrhythmia
Regubeat 100mg Tablet is used to stabilize heart rhythms (particularly atrial fibrillation). It helps in normalizing an abnormal heart rhythm, preventing it from occurring in the first place, or slowing down the heart rate during an episode. Take it regularly and keep taking it even if you feel better.
Side effects of Regubeat Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Regubeat
- Constipation
- Chest pain
- Difficulty in urination
- Xerostomia
How to use Regubeat Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Regubeat 100mg Tablet is to be taken empty stomach.
Safety advice
Alcohol
CAUTION
Caution is advised when consuming alcohol with Regubeat 100mg Tablet. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Regubeat 100mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Regubeat 100mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
UNSAFE
Regubeat 100mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
CAUTION
Regubeat 100mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Regubeat 100mg Tablet may be needed. Please consult your doctor.
Liver
CAUTION
Regubeat 100mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Regubeat 100mg Tablet may be needed. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- It may cause dizziness. Do not drive or perform activities require mental focus until you know how it affects you.
- Do not start any medicine including prescription or over-the-counter medicines without informing your doctor, as they may alter Regubeat 100mg Tablet levels in your body.
- Your doctor may get blood tests done to check your sodium and potassium levels, kidney function, and lung function before starting treatment with this medicine.
- Your doctor may regularly monitor blood sugar level while taking this medicine.
- Inform your doctor if you experience slow or fast heart rate, chest pain, shortness of breath.
- Inform your doctor if you are pregnant or planning to conceive or breastfeeding.
- Do not stop taking medication suddenly without talking to your doctor.
Fact Box
Chemical Class
Pheniramines derivatives
Habit Forming
No
Therapeutic Class
CARDIAC
Action Class
Class I Agents- anti arrhythmic
Patient concerns
User feedback
Patients taking Regubeat 100mg Tablet
Thrice A Day
40%
Once A Day
30%
Twice A Day
25%
Alternate Day
5%
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Sampson KJ, Kass RS. Anti-Arrhythmic Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 839.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 419-20.
- Hume JR, Grant AO. Agents used in cardiac arrhythmias: Disopyramide (Subgroup 1A). In: Katzung BG, masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi: Tata McGraw Hill; 2009. pp. 238-39.
- Drugs.com. Disopyramide Pregnancy and Breastfeeding Warnings. [Accessed 15 Mar. 2019] (online) Available from:
- Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198. [Accessed 15 Mar. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). Disopyramide. [Accessed 15 Mar. 2019] (online) Available from:
Marketer details
Name: Glaxo SmithKline Pharmaceuticals Ltd
Address: Dr. Annie Besant Road, Mumbai - 400 030
Country of origin: India
Lab tests offered by us
Related/Popular tests
240 people viewed this recentlyDISCONTINUED
We do not facilitate sale of this product at present